Double-blindness procedure did not mask giving of medication in panic disorder

Journal of Affective Disorders

Volumn 54, Issue 1-2, 1999, Pages 189-192

  Bakker, Abraham ^a,b   Spinhoven, Philip ^c   Van Balkom, Anton J L M ^a,b   Matser, Dick ^a   Van Dyck, Richard ^a,b  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; PAROXETINE; PLACEBO;

AGORAPHOBIA; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

CLOMIPRAMINE; DOUBLE-BLIND METHOD; HUMANS; PANIC DISORDER; PAROXETINE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0032995192     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(98)00147-5     Document Type: Article

References (5)

1. Bakker, A., Van Dyck, R., Spinhoven, P., Van Balkom, A.J.L.M. Paroxetine, clomipramine and cognitive therapy in the treatment of panic disorder, submitted for publication.
2. Ballenger, J.C., Wheadon, D.E., Steiner, M., Bushnell, W., Gergel, I.P., 1998. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am. J. Psychiatry 155, 36-42.
3. Basoglu, M., Marks, I.M., Livanou, M., Swinson, R., 1997. Double-blindness procedures, rater blindness, and ratings of outcome. Arch. Gen. Psychiatry 54, 744-748.
4. Fisher, S., Greenberg, R.P., 1993. How sound is the double-blind design for evaluating psychotropic drugs?. J. Nerv. Ment. Dis. 181, 345-350.
5. Kleijnen, J., de Craen, A.J., van Everdingen, J., Krol, L., 1994. Placebo effect in double-blind clinical trials: A review of interactions with medications. Lancet 344, 1347-1349.